FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data

被引:7
作者
Lu, Ying [1 ]
Shao, Jing [2 ]
Shu, Xu [1 ]
Jiang, Yaofei [2 ]
Rong, Jianfang [1 ]
Lai, Yongkang [1 ]
Liu, Ji [3 ]
机构
[1] Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Peoples R China
[3] Nanchang Univ, Dept Urol, Affiliated Hosp 1, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China
关键词
FADS1; bladder cancer; poor prognosis; biomarker; TCGA; survival; POLYUNSATURATED FATTY-ACIDS; SUSCEPTIBILITY LOCUS; BREAST-CANCER; EXPRESSION; RATIO; N-3;
D O I
10.2174/1386207323666200925104911
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aim and Objective: Fatty acid desaturase 1 (FADS1) has been reported to be a potential biomarker in various cancers. However, no study has explored the relationship between FADS1 expression and bladder cancer. Our study aimed to investigate the role of FADS1 in bladder cancer prognosis via The Cancer Genome Atlas (TCGA). Materials and Methods: RNA-Seq expression of 414 tumor tissues and 19 paired normal tissues, as well as corresponding clinical data, were downloaded from the TCGA database. Two cancer cases were excluded due to a lack of clinical information. The association between FADS1 and the clinicopathological features of bladder cancer was analyzed. This study was conducted in October 2019 in China. Results: The high expression of FADS1 in bladder cancer was significantly related to histological grade (OR = 0.155 for low vs. high), clinical stage (OR = 2.074 for III or IV vs. I or II), T classification (OR = 2.326 for T3 or T4 vs. T1 or T2), lymphatic metastasis (OR = 1.923 for N1 or N2 or N3 vs. N0) and distant metastasis (OR=4.883 for yes vs. no) (all p-values <0.05). Bladder cancer with high FADS1 levels was related to a worse prognosis than bladder cancer with low FADS1 levels (p = 1.626*10(-5)), according to median expression value 3.622. FADS1 was an independent factor of overall survival in bladder cancer, with a hazard ratio of 1.048 (95%CI: 1.020-1.077, p = 0.001). Conclusion: Increased FADS1 expression in bladder cancer is associated with advanced clinico-pathological features and may be a potential biomarker for poor prognosis.
引用
收藏
页码:1197 / 1204
页数:8
相关论文
共 31 条
  • [1] Protective properties of n-3 fatty acids and implications in obesity-associated breast cancer
    AL-Jawadi, Arwa
    Moussa, Hanna
    Ramalingam, Latha
    Dharmawardhane, Suranganie
    Gollahon, Lauren
    Gunaratne, Preethi
    Rahman, Rakhshanda Layeequr
    Moustaid-Moussa, Naima
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2018, 53 : 1 - 8
  • [2] Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
    Antoni, Sebastien
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Znaor, Ariana
    Jemal, Ahmedin
    Bray, Freddie
    [J]. EUROPEAN UROLOGY, 2017, 71 (01) : 96 - 108
  • [3] Dietary fatty acids modulation of human colon cancer cells: mechanisms and future perspectives
    Brandao, D.
    Ribeiro, L.
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2018, 69 (04) : 437 - 450
  • [4] Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
    Calder, Philip C.
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2008, 52 (08) : 885 - 897
  • [5] Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage
    Chapman, K
    Mustafa, Z
    Irven, C
    Carr, AJ
    Clipsham, K
    Smith, A
    Chitnavis, J
    Sinsheimer, JS
    Bloomfield, VA
    McCartney, M
    Cox, O
    Cardon, LR
    Sykes, B
    Loughlin, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) : 167 - 174
  • [6] FADS1 rs174549 Polymorphism May Predict a Favorable Response to Chemoradiotherapy in Oral Cancer Patients
    Chen, Fa
    He, Baochang
    Yan, Lingjun
    Qiu, Yu
    Lin, Lisong
    Cai, Lin
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2017, 75 (01) : 214 - 220
  • [7] Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Efstathiou, Jason A.
    Mouw, Kent W.
    Gibb, Ewan A.
    Liu, Yang
    Wu, Chin-Lee
    Drumm, Michael R.
    da Costa, Jose Batista
    du Plessis, Marguerite
    Wang, Natalie Q.
    Davicioni, Elai
    Feng, Felix Y.
    Seiler, Roland
    Black, Peter C.
    Shipley, William U.
    Miyamoto, David T.
    [J]. EUROPEAN UROLOGY, 2019, 76 (01) : 59 - 68
  • [8] A New Model to Study the Role of Arachidonic Acid in Colon Cancer Pathophysiology
    Fan, Yang-Yi
    Callaway, Evelyn
    Monk, Jennifer M.
    Goldsby, Jennifer S.
    Yang, Peiying
    Vincent, Logan
    Chapkin, Robert S.
    [J]. CANCER PREVENTION RESEARCH, 2016, 9 (09) : 750 - 757
  • [9] Omega-3 fatty acids, membrane remodeling and cancer prevention
    Fuentes, Natividad R.
    Kim, Eunjoo
    Fan, Yang-Yi
    Chapkin, Robert S.
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2018, 64 : 79 - 91
  • [10] Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
    Hautmann, Richard E.
    de Petriconi, Robert C.
    Pfeiffer, Christina
    Volkmer, Bjoern G.
    [J]. EUROPEAN UROLOGY, 2012, 61 (05) : 1039 - 1047